BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.
Founded in 1997, Labochema is a provider of integrated laboratory solutions, with branches in all three Baltic countries. It also controls Gidela, a fast-growing laboratory furniture company. The companies employ more than 50 people. The company had US$15.1 million revenues in 2020.
Dutscher is one of the leading European laboratory supply distributors, with annual revenues of US$365 million and 700 employees in nine countries. Since 2020, the company is owned by private equity fund manager LBO France (with US$7.3 billion assets under management) and the management team, led by Dominique Wencker. Based in France, Dutscher has experienced strong organic growth complemented by targeted acquisitions in France, Spain, Italy and the UK.
Oaklins’ team in Lithuania acted as a full-scope M&A advisor to the sellers through all stages of the process.
Talk to the deal team
Related deals
Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
Learn moreInfotreasury has been sold to Matera
Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.
Learn moreThrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH
Paradiesfrucht GmbH, a gobal freeze dryer of fruits, fruit preparations, drops, powders and granulates, has been acquired by Thrive Freeze Dry (Thrive), a portfolio company of Entrepreneurial Equity Partners (e2p) and Mubadala Capital. The transaction is expected to close in 2024, subject to customary closing conditions, including antitrust approval.
Learn more